News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon
NanoViricides, Inc. announces Phase II Clinical Trial of NV-387 Oral Gummies for Ebola viruses led by Prof. Patrick Katoto in DRC. Trial response to growing Bundibugyo outbreak -
-
-
COMMUNIQUÉ DE PRESSE
Elmos Semiconductor SE: Extraordinary General Meeting elects new members to the Supervisory Board
Elmos Semiconductor SE's Extraordinary General Meeting elects new members to the Supervisory Board, ensuring generational transition. Strategic objectives and corporate governance key focus -